These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25320504)

  • 21. Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer.
    Pandey M; Mukhopadhyay A; Sharawat SK; Kumar S
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188552. PubMed ID: 33892053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2.
    An Y; Zhang Z; Shang Y; Jiang X; Dong J; Yu P; Nie Y; Zhao Q
    Cell Death Dis; 2015 May; 6(5):e1766. PubMed ID: 25996293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
    Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
    EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma.
    Zhang X; Peng Y; Jin Z; Huang W; Cheng Y; Liu Y; Feng X; Yang M; Huang Y; Zhao Z; Wang L; Wei Y; Fan X; Zheng D; Meltzer SJ
    Oncotarget; 2015 Oct; 6(32):32878-89. PubMed ID: 26460735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer.
    Mu YP; Sun WJ; Lu CW; Su XL
    Asian Pac J Cancer Prev; 2015; 16(12):4813-20. PubMed ID: 26163596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.
    Yang W; Ma J; Zhou W; Cao B; Zhou X; Yang Z; Zhang H; Zhao Q; Fan D; Hong L
    Expert Opin Ther Targets; 2017 Nov; 21(11):1063-1075. PubMed ID: 28994330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer.
    Ahadi A
    Immunogenetics; 2021 Apr; 73(2):155-161. PubMed ID: 33399935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical crosstalk between microRNAs and gastric cancer (Review).
    Ouyang J; Xie Z; Lei X; Tang G; Gan R; Yang X
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine.
    Wang S; Yuan L
    Biosci Trends; 2016 Jul; 10(3):171-80. PubMed ID: 27251446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs and cancer: towards a personalized medicine.
    Fabbri M
    Curr Mol Med; 2013 Jun; 13(5):751-6. PubMed ID: 23642056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of microRNAs in gastric cancer.
    Ishiguro H; Kimura M; Takeyama H
    World J Gastroenterol; 2014 May; 20(19):5694-9. PubMed ID: 24914330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.
    Li L; Cui Y; Ye L; Zhao Z; Jiang WG; Ji J
    Int J Oncol; 2018 Sep; 53(3):1171-1182. PubMed ID: 29956751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment.
    Mirzajani E; Vahidi S; Norollahi SE; Samadani AA
    Microrna; 2022; 11(1):12-24. PubMed ID: 35319404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs as promising biomarkers for gastric cancer.
    Wang F; Sun GP; Zou YF; Hao JQ; Zhong F; Ren WJ
    Cancer Biomark; 2012; 11(6):259-67. PubMed ID: 23248184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
    Gerhards NM; Rottenberg S
    Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
    Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
    World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in the molecular diagnostics of gastric cancer.
    Kanda M; Kodera Y
    World J Gastroenterol; 2015 Sep; 21(34):9838-52. PubMed ID: 26379391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.
    Hong L; Han Y; Yang J; Zhang H; Zhao Q; Wu K; Fan D
    Expert Opin Biol Ther; 2014 Aug; 14(8):1103-11. PubMed ID: 24707835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancer.
    Qi M; Liu D; Zhang S
    Cancer Biomark; 2017; 18(4):451-458. PubMed ID: 28128744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.